#IOLChemicals #Q2Results #APIManufacturing #PharmaGrowth #EDQM #CEP #EBITDA #ProfitGrowth #SpecialtyChemicals

IOL Chemicals Reports 56.7% YoY Profit Surge in Q2 FY26, Driven by Operational Efficiency and Non-Ibuprofen APIs

IOL Chemicals Reports 56.7% YoY Profit Surge in Q2 FY26, Driven by Operational Efficiency and Non-Ibuprofen APIs

#IOLChemicals #Q2Results #APIManufacturing #PharmaGrowth #EDQM #CEP #EBITDA #ProfitGrowth #SpecialtyChemicals Chandigarh: IOL Chemicals and Pharmaceuticals Ltd (IOLCP) has announced robust standalone financial results for the second quarter (Q2) of FY26, reporting a significant surge in profitability driven by improved operating leverage and a strategic focus on its diverse product portfolio. The company's Profit After Tax (PAT) soared by 56.7% year-on-year (YoY) to ₹30.0 Crore in Q2 FY26, up from ₹19.2 Crore in Q2 FY25. This strong bottom-line growth was supported by a 33.3% YoY jump in EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) to ₹64.0 Crore. 📈 Financial Performance Snapshot…
Read More